Status:
WITHDRAWN
Comparison of Pre-procedural PCR and Culture-based UTI Assessment Prior to Intravesical Botox Injection
Lead Sponsor:
Pathnostics
Conditions:
Urinary Tract Infections
Eligibility:
All Genders
18+ years
Brief Summary
This study is a retrospective record review to determine whether a novel multiplex PCR assay can be utilized as a screening method for UTI in patients receiving Botox injection to treat overactive bla...
Detailed Description
The novel multiplex real-time PCR assay with mixed floral antibiotic resistance profiling offers a higher degree of sensitivity and specificity than conventional culture methods in the identification ...
Eligibility Criteria
Inclusion
- Inclusion/Exclusion Criteria:
- Subject is male or female
- \>18 years of age at date of injection
- Subject receiving BoNT injection for symptoms of OAB (including urgency, urinary incontinence, and detrusor overactivity) refractory to first-line therapies
Exclusion
Key Trial Info
Start Date :
August 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04817865
Start Date
August 15 2020
End Date
July 31 2023
Last Update
November 18 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Comprehensive Urologic Care
Barrington, Illinois, United States, 60010